Skip to main content
SpringerLink
Log in

Prophylactic effect of tixagevimab–cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

Inquiries for data should be directed to tatetsu@kumamoto-u.ac.jp. The data will be available for achieving aims in the approved proposal.

References

  1. Pagano L, Salmanton-García J, Marchesi F, López-García A, Lamure S, Itri F, et al. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. Blood. 2022;139:1588–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Okamoto A, Fujigaki H, Iriyama C, Goto N, Yamamoto H, Mihara K, et al. CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma. Blood Adv. 2022;6:3230–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Levin MJ, Ustianowski A, De Wit S, Launay O, Avila M, Templeton A, et al. Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of covid-19. N Engl J Med. 2022;386:2188–200.

    Article  CAS  PubMed  Google Scholar 

  4. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl. 2013;48:452–8.

    Article  CAS  Google Scholar 

  5. Busca A, Salmanton-García J, Corradini P, Marchesi F, Cabirta A, Di Blasi R, et al. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood Adv. 2022;6:2427–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was partially supported by a grant from JSPS KAKENHI (grant number: 21K08420). The authors would like to thank the medical, nursing, laboratory, and clinical staff at the participating center for their important contributions to this study and their dedicated patient care.

Funding

This work was partially supported by a grant from JSPS KAKENHI (grant number: 21K08420).

Author information

Authors and Affiliations

  1. Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan

    Hiro Tatetsu, Yusuke Higuchi, Takafumi Shichijo, Hirotomo Nakata, Jun-ichirou Yasunaga, Kisato Nosaka & Masao Matsuoka

  2. Department of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan

    Kazutaka Oda

Authors
  1. Hiro Tatetsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yusuke Higuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takafumi Shichijo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazutaka Oda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirotomo Nakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun-ichirou Yasunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kisato Nosaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masao Matsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: Hiro Tatetsu, Takafumi Shichijo. Provision of study materials or patients: all authors. Collection and assembly of data: Hiro Tatetsu, Yusuke Higuchi, Kazutaka Oda and Kisato Nosaka. Data analysis: Takafumi Shichijo and Hiro Tatetsu. Interpretation of data: all authors. Manuscript writing: Hiro Tatetsu, Takafumi Shichijo, Kazutaka Oda, Jun-ichirou Yasunaga, Kisato Nosaka, and Masao Matsuoka. Final approval of manuscript: all authors.

Corresponding author

Correspondence to Hiro Tatetsu.

Ethics declarations

Conflict of interest

HT has received honoraria from AstraZeneca, Bristol Myers Squibb, Chugai Pharmaceutical, Eisai, Novartis, SymBio Pharmaceuticals Limited, and Takeda Pharmaceutical, Meiji Seika Pharma as well as patents and royalties from Mesoblasts. KN has received consultancy fees, research funding, honoraria from Kyowa Kirin, research funding from Chugai Pharmaceutical, and honoraria from Celgene, Eisai, Meiji Seika Pharma, Janssen Pharmaceutical, Abbvie Inc., and Bristol Myers Squibb. MM received research funding from Chugai Pharmaceuticals and Kyowa Kirin. YH, TS, KO, HN, J-iY have no conflicts of interest to declare.

Ethical approval

This study was approved by the Institutional Review Board of Kumamoto University Hospital (No. 2226) and was conducted in accordance with the principles of the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

12185_2023_3629_MOESM1_ESM.docx

Supplementary file1 (DOCX 25 KB) Table S1 Clinical characteristics of B-cell lymphoma patients who received tixagevimab–cilgavimab

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tatetsu, H., Higuchi, Y., Shichijo, T. et al. Prophylactic effect of tixagevimab–cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma. Int J Hematol 118, 303–305 (2023). https://doi.org/10.1007/s12185-023-03629-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-023-03629-4

Keywords

Search

Navigation